Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 4Sarcoma 2Triple Negative Breast Neoplasms 1Sarcoma, Synovial 1Pheochromocytoma 1Neurofibrosarcoma 1Neuroblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Liposarcoma 1Leiomyosarcoma 1Inflammatory Breast Neoplasms 1Histiocytoma, Malignant Fibrous 1Hematologic Neoplasms 1Fibrosarcoma 1Breast Neoplasms, Male 1

Interventions

Standard of Care 9Exercise 9Educational Status 8Practice Guidelines as Topic 7Methods 7Blood Specimen Collection 7Early Intervention, Educational 6Palliative Care 5Interviews as Topic 5Behavior Therapy 5fludarabine 4Surveys and Questionnaires 4Physical Therapy Modalities 4Cyclophosphamide 4Magnetic Resonance Spectroscopy 3Health Promotion 3Granulocyte Colony-Stimulating Factor 3pegylated granulocyte colony-stimulating factor 2fludarabine phosphate 2Whole-Body Irradiation 2Therapeutic Touch 2Stem Cell Transplantation 2Restraint, Physical 2Radiosurgery 2Patient Navigation 2Parenteral Nutrition 2Low-Level Light Therapy 2Etoposide 2Cytarabine 2Control Groups 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hematologic Neoplasms × pegfilgrastim × Clear all
NCT00689884 2018-04-20

Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies

Dartmouth-Hitchcock Medical Center

Phase NA Terminated
7 enrolled 4 charts
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡